SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001493152-19-016847
Filing Date
2019-11-12
Accepted
2019-11-12 09:29:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 42890
  Complete submission text file 0001493152-19-016847.txt   43908
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations